4-1002459-C-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000203.5(IDUA):āc.1163C>Gā(p.Thr388Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000444 in 1,553,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Synonymous variant affecting the same amino acid position (i.e. T388T) has been classified as Benign.
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDUA | NM_000203.5 | c.1163C>G | p.Thr388Arg | missense_variant | 8/14 | ENST00000514224.2 | NP_000194.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDUA | ENST00000514224.2 | c.1163C>G | p.Thr388Arg | missense_variant | 8/14 | 2 | NM_000203.5 | ENSP00000425081 | P1 | |
IDUA | ENST00000247933.9 | c.1163C>G | p.Thr388Arg | missense_variant | 8/14 | 1 | ENSP00000247933 | P1 | ||
IDUA | ENST00000514698.5 | n.1270C>G | non_coding_transcript_exon_variant | 5/11 | 5 | |||||
IDUA | ENST00000652070.1 | n.1219C>G | non_coding_transcript_exon_variant | 7/13 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.0000471 AC: 66AN: 1401078Hom.: 0 Cov.: 35 AF XY: 0.0000419 AC XY: 29AN XY: 691618
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152148Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74318
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 05, 2022 | Variant summary: IDUA c.1163C>G (p.Thr388Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 153708 control chromosomes. c.1163C>G has been reported in the literature in multiple individuals affected with Mucopolysaccharidosis Type 1 (e.g. Wang_2011, Ghosh_2017). These data indicate that the variant is very likely to be associated with disease. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 18, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 388 of the IDUA protein (p.Thr388Arg). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with mucopolysaccharidosis Type I (PMID: 14516901, 17606547, 21253827, 21963080, 28752568). ClinVar contains an entry for this variant (Variation ID: 496834). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on IDUA protein function. This variant disrupts the p.Thr388 amino acid residue in IDUA. Other variant(s) that disrupt this residue have been observed in individuals with IDUA-related conditions (PMID: 27520059), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 14, 2020 | The p.Thr388Arg variant in IDUA has been reported in at least 9 individuals with mucopolysaccharidosis (MPS) (PMID: 28752568, 21963080, 28728811, 21253827) and has been identified in 0.001% (1/74540) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs794727896). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 496834) as likely pathogenic by EGL Genetic Diagnostics and Counsyl. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in combination with reported pathogenic variants in at least 7 individuals with MPS increases the likelihood that the p.Thr388Arg variant is pathogenic (VariationID: 11908, 11910, 550799, 11917; PMID: 28752568, 21963080, 28728811, 21253827). In summary, this variant meets criteria to be classified as pathogenic for MPS in an autosomal recessive manner based on the presence of the variant in combination with other pathogenic variants in individuals with MPS, its low frequency in the general population, and computational evidence. ACMG/AMP Criteria applied: PM3_very-strong, PM2, PP3 (Richards 2015). - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 09, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 13, 2017 | - - |
Hurler syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Feb 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at